secwatch.observer — SEC 8-K summary
======================================

Issuer:     INNOVATE Corp. (VATE)
CIK:        0001006837
Form:       8-K
Filed at:   2026-08-18T12:12:19+00:00
Accession:  0001006837-26-000090
Event type: other_material
Sentiment:  positive
Materiality: 0.25
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INNOVATE's MediBeacon TGFR System nominated for 2026 Prix Galien USA Best Medical Technology
--------------------------------------------------------------------------------

- MediBeacon TGFR System nominated for 2026 Prix Galien USA Best Medical Technology by The Galien Foundation.
- Winners announced Oct 29, 2026 at American Museum of Natural History in New York City.
- TGFR System is first-in-kind point-of-care kidney function assessment using Lumitrace injection, monitor, and reusable sensor.
- Earlier in 2026, JASN recognized a transdermal GFR assessment article as one of five Editor's Choice articles of 2025.
- MediBeacon is an equity method investment of INNOVATE (NYSE: VATE).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1006837/000100683726000090/0001006837-26-000090-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1006837/000100683726000090/hchc-20260818.htm
  HTML page:      https://secwatch.observer/filing/0001006837-26-000090

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer